Skip to main content

What the FDA labels say about taking them together

Lurasidone and nafcillin

Lurasidone's FDA label of January 31, 2025 names nafcillin in its drug interactions section; the nafcillin labels PlainMeds reads (2) do not name lurasidone. The lurasidone label: “Concomitant use of LATUDA with moderate CYP3A4 inducers decreased the exposure of lurasidone compared to the use of LATUDA alone.”

Check it at the source: the lurasidone FDA label on DailyMed (effective January 31, 2025, Sumitomo Pharma America, Inc.); the nafcillin FDA label on DailyMed (effective March 9, 2026, ONESOURCE SPECIALTY PHARMA LIMITED).

What does the lurasidone label say about nafcillin?

Lurasidone label, drug interactions

Moderate CYP3A4 Inducers Clinical Impact: Concomitant use of LATUDA with moderate CYP3A4 inducers decreased the exposure of lurasidone compared to the use of LATUDA alone. Intervention: LATUDA dose should be increased when used concomitantly with moderate inducers of CYP3A4 [see Dosage and Administration ()]. Examples: Bosentan, efavirenz, etravirine, modafinil, nafcillin

Source: FDA drug label (Latuda), NDA200603 (Sunovion Pharms Inc), as published by Sumitomo Pharma America, Inc., effective January 31, 2025 (SPL set afad3051-9df2-4c54-9684-e8262a133af8), via openFDA; the full label on DailyMed

What does the nafcillin label say about lurasidone?

Nafcillin's label (effective March 9, 2026) and its 1 other brand-application label do not name lurasidone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (NAFCILLIN SODIUM), ONESOURCE SPECIALTY PHARMA LIMITED, effective March 9, 2026 (SPL set 4b3b8e52-df96-4886-e063-6294a90ac63f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

28Lurasidone generic labelers
9Nafcillin generic labelers
LurasidoneNafcillin
Labeled forSchizophrenia, Bipolar disorder, Depressionn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.142 per tablet 20 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?